EL SEGUNDO, Calif. — Gov. Gavin Newsom announced Thursday that CalRx biosimilar insulin glargine pens will be available to consumers in California beginning Jan. 1, 2026. The launch comes amid the ...
(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...
California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...
California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.
Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...
California Gov. Gavin Newsom (D) announced Thursday that cheaper, state-made insulin for diabetics, an endeavor he unveiled more than three years ago, is set to hit shelves in January. A five-pack of ...
The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...
This is read by an automated voice. Please report any issues or inconsistencies here. Gov. Gavin Newsom said $11 insulin pens will soon be available through the state’s pharmaceutical label.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback